Electrophysiology Treatment for Arrhythmia

There is a bidirectional relationship between research and clinical care. Research at the highest level helps improve outcomes, while challenges faced in clinical care raise the next questions that will advance treatment options.CIC_Feb_AF2

The electrophysiology (EP) lab at the University of Michigan Frankel Cardiovascular Center is one of the preeminent facilities for EP in the United States. “

We have been a pioneer and leader for many of the techniques that have improved outcomes in patients with complex and difficult-to-treat arrhythmias, with a comprehensive focus on the patient, and we have had excellent outcomes,” said Hakan Oral, MD, director of Cardiac Electrophysiology.

TREATMENT OPTIONS

Whether patients are referred for atrial fibrillation (AF), paroxysmal supraventricular tachycardia, Wolff-Parkinson-White (WPW) syndrome, life-threatening ventricular arrhythmias or for cardiac implantable devices such as ICDs, pacemakers, cardiac resynchronization therapy or other devices for prevention of stroke in patients with AF, the Cardiac Arrhythmia Service at the Frankel Cardiovascular Center is well prepared to offer optimal therapeutic options.

For AF, the Cardiac Arrhythmia Service has been one of the pioneers and a leader in ablation of AF and other arrhythmias—specifically ventricular arrhythmias—and has helped to move the field forward. “AF, and ventricular arrhythmias in general, has been a rapidly expanding field, and it is important for the clinicians who first see these patients to understand there are advanced treatment options,” said Dr. Oral. “There are many opportunities to help these patients.”

THE TEAM

The Cardiac Arrhythmia Service has nine faculty clinical cardiac electrophysiologists with substantial expertise and experience in their CIC_Feb_teamfields, both in clinical care and research. Drs. Fred Morady, Frank Bogun, Aman Chugh, Frank Pelosi, Thomas Crawford, Rakesh Latchamsetty, Hamid Ghanbari, Ryan Cunnane and Oral have collectively contributed more than 500 peer-reviewed studies in advancing the field of electrophysiology over the last decades.

In addition to its faculty, a major strength of the Cardiac Arrhythmia Service is the dedicated team of nurse practitioners, physician assistants, nurses, technologists and staff who help to deliver ideal patient experiences and play a critical role in this clinical mission.

ATRIAL FIBRILLATION

AF is the most common sustained arrhythmia, with surging incidence and prevalence rates over the past two decades. This increase has been particularly steep in the United States, which has one of the highest incidence rates on a per-capita basis in the world. AF places patients at increased risk for thromboembolic events, stroke, heart failure and death.

CIC_Feb_Oral

Hakan Oral, MD

“ It is important for the clinicians who first see these patients to understand that there are advanced treatment options. The most important is proper and timely identification of the patients who may benefit from more advanced specialized diagnostic and treatment options.”

—Hakan Oral, MD

 

Leave a Reply

Your email address will not be published. Required fields are marked *